Case Study: Accelerating drug discovery at the Melbourne Biomedical Precinct
14 May 2020 33% of Australia’s 2017-2018 drug discovery efforts occurred within the Melbourne Biomedical Precinct (the Precinct) and continues to grow. The Precinct consistently attracts 23% of National Health and Medical Research Council (NHMRC) funding annually, more…
Public information key to combatting rising ‘superbug’ threat
14 May 2020 With predictions that drug-resistant ‘superbugs’ could cause up to 10 million deaths a year by 2050, a new CSIRO survey has revealed a low level of community knowledge about antibiotics. The rise of superbugs, which…
Mucus breakthrough could help patients breathe easy
14 May 2020 A discovery about how mucus thickness is regulated could help to improve airway-clearing treatment options for people with chronic respiratory conditions such as asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD). New insights into…
MTPConnect – 2020 Sector Competitiveness Plan
14 May 2020 In November of 2015, MTPConnect was established as an independent, not-for-profit organisation to drive connectivity, innovation, productivity and competitiveness in Australia’s medical technology, biotechnology and pharmaceuticals sector. In 2016, MTPConnect published a foundation plan for…
Blood test a potential new tool for controlling infections
12 May 2020 Researchers at the Walter and Eliza Hall Institute have published a new technique which could provide vital information about a community’s immunity to infectious diseases – including malaria and COVID-19. The diagnostic test analyses a…
Healthcare efficiency: AI technology to reduce hospital readmissions
11 May 2020 Monash University researchers are using Artificial Intelligence (AI) to better understand the cause of hospital readmissions, in turn improving health outcomes and reducing the financial burden on the health system. In the biggest study of…
Australian Medtech Startup is Using AI to Help Newborns in Intensive Care
6 May 2020 This article has been shared from Hive Life and is written by Stephanie H. Read the full original article here. Umbilical venous catheterisation is an emergency procedure performed on premature and critically ill newborns who…
CE mark for Trajan’s hemaPEN® blood microsampling device, now available for diagnostic use across EU and UK
7 May 2020 Trajan Scientific and Medical (Trajan) has declared hemaPEN® compliance with EU IVD Directive 98/79/EC, and its release for in vitro diagnostic use in the EU and UK. This follows the hemaPEN’s recent addition to the…
Certara & DMTC Collaborate to Study Using Chloroquine in Healthcare Workers at Risk for COVID-19
7 May 2020 Certara®, the global leader in model-informed drug development, and DMTC (formerly the Defence Materials Technology Centre) Ltd, which works to enhance Australia’s defense and medical countermeasure capabilities, have entered into a…
Cynata Receives Ethics Approval to Commence Clinical Trial in COVID-19 and Clinical Development Update
8 May 2020 Cynata Therapeutics Limited, a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that it has received ethics committee approval to commence a clinical trial to investigate early efficacy of Cynata’s proprietary CymerusTM…
Florey researchers to pursue first-in-clinic treatment for severe infant epilepsy
8 May 2020 Researchers at the Florey, in collaboration with the University of Melbourne, will pursue a potentially life-changing precision medicine treatment for children with severe forms of epilepsy, thanks to a new multi-year grant awarded from the…
AdAlta update: Dr Tim Oldham interviewed by Pitt Street Research
8 May, 2020 Our CEO, Dr Tim Oldham recently sat down with Stuart Roberts of Pitt Street research to talk about AdAlta’s growth strategy and upcoming Phase 1 clinical trials of lead candidate, AD-214. In the interview, Dr…
